obesity drug news today glp-1 october 27 2025 Chart: 1 in 8 Americans Now Use Drugs for Weight Loss Pharma Giants Bet on Next-Generation
Description
An Update On Dpp 4 Inhibitors In The Management Of Type 2 Diabetes SGLT2 Inhibitors in Diabetes Management by Dr Shahjada Selim Diabetes and new anti diabetic drugs Sodium glucose co transporter( SGLT2) Inhibitors Incretins In Diabetes Mellitus SGLT2 inhibitors in Diabetic Kidney Disease Dpp4i earlier the better
Diets with high or low protein content and glycemic index for weight-loss maintenance
However, the most significant phase 3 trial (EXENATIDE-PD3), which used exenatide once weekly over 96 weeks in 194 people with Parkinsons disease, found no evidence to support exenatide as a disease-modifying treatment [121]
Vitamin B12 deficiency: Long-term use can lower B12 levels, raising anemia and nerve damage risk
Charbonnel B, Karasik A, Liu J, et al
